Cargando…
Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
BACKGROUND: Covid-19 infection and cancer are associated with an increased risk of thrombotic events. The aim of our study is to analyze the cumulative incidence of thrombosis in oncological patients with Covid-19 and detect differences with the non-cancer Covid-19 population. METHODS: We retrospect...
Autores principales: | Obispo, Berta, Rogado, Jacobo, Muñoz-Rivas, Nuria, Pangua, Cristina, Serrano, Gloria, Lara, Miguel Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463388/ https://www.ncbi.nlm.nih.gov/pubmed/34674859 http://dx.doi.org/10.1016/j.medcli.2021.08.002 |
Ejemplares similares
-
Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
por: Obispo, Berta, et al.
Publicado: (2022) -
COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic()
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020) -
Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors
por: Rogado, Jacobo, et al.
Publicado: (2021) -
Incidence of Thromboembolic Events in Cancer Hospitalized Patients With COVID-19
por: Rogado, Jacobo, et al.
Publicado: (2021) -
Mortalidad por COVID-19 en pacientes con cáncer en un hospital de Madrid durante las primeras 3 semanas de epidemia
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020)